Combination of alpha lipoic acid and superoxide dismutase leads to physiological and symptomatic improvements in diabetic neuropathy

Drugs in R and D

Volumn 12, Issue 1, 2012, Pages 29-34

  Bertolotto, Fulvio ^a   Massone, Antonino ^a  

^a SANTA CORONA HOSPITAL   (Italy)

Author keywords

Diabetes mellitus; Diabetic neuropathies; Superoxide dismutase; Thioctic acid

Indexed keywords

ALA 600 SOD; ALPHA LIPOIC ACID PLUS SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE; THIOCTIC ACID; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIABETES MELLITUS; DIABETIC NEUROPATHY; DRUG EFFICACY; DRUG SAFETY; ELECTRONEUROGRAPHY; FEMALE; HUMAN; MALE; MOTOR DYSFUNCTION; NOCICEPTION; PAIN ASSESSMENT; PRIORITY JOURNAL; SENSORY DYSFUNCTION; SENSORY NERVE CONDUCTION; VISUAL ANALOG SCALE;

AGED; AMBULATORY CARE; ANTIOXIDANTS; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; NEURAL CONDUCTION; PAIN MEASUREMENT; PERONEAL NERVE; PILOT PROJECTS; PROSPECTIVE STUDIES; SUPEROXIDE DISMUTASE; SURAL NERVE; THIOCTIC ACID; TREATMENT OUTCOME;

EID: 84858691016     PISSN: 11745886     EISSN: 11796901     Source Type: Journal    
DOI: 10.2165/11599200-000000000-00000     Document Type: Article

References (30)

1. Mijnhout GS, Alkhalaf A, Kleefstra N, et al. Alpha lipoic acid: a new treatment for neuropathic pain in patients with diabetes? Neth J Med 2010; 68 (4): 158-62
2. Van Acker K, Bouhassire D, De Bacquer D, et al. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropatic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes Metab 2009; 35: 206-13
3. Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005; 28: 956-62 (Pubitemid 40434506)
4. Vallianou N, EVangelopoulos A, Koutalas P. Alpha-lipoic acid and diabetic neuropathy. Rev Diabet Stud 2009; 6 (4): 230-6
5. Daousi C, Benbow SJ, Woodward A, et al. The natural history of chronic painful peripheral neuropathy in a community diabetes population. Diabet Med 2006; 23: 1021-4 (Pubitemid 44257948)
6. Davies M, Brophy S, Williams R, et al. The prevalence, severity and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 2006; 29: 1518-22 (Pubitemid 44127574)
7. Greco D, Bambina F, Pisciotta M, et al. Clinical characteristics and associated comorbidities in diabetic patients with cranial nerve palsies. J Endocrinol. Epub 2011 Mar 7
8. Gries FA, Cameron NE, Low PA, et al. Textbook of diabetic neuropathy. Stuttgart: Thieme, 2003
9. Ziegler D, Ametov A, Barinov A, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the Sydney 2 Trial. Diabetes Care 2006; 29: 2365-70 (Pubitemid 44912237)
10. Ceriello A, Testa R. Antioxidant anti-inflammatory treatment in type 2 diabetes. Diabetes Care 2009; 32 Suppl. 2: S232-6
11. Vincent AM, Edwards JL, Sadidi M, et al. The antioxidant response as a drug target in diabetic neuropathy. Curr Drug Targets 2008; 9: 94-100
12. Ziegler D, Sohr CGH, Nourooz-Zadeh J. Oxidative stress and antioxidant defense in relation to the severity of diabetic polineuropathy and cardiovascular autonomic neuropathy. Diabetes Care 2004; 27 (9): 2178-83 (Pubitemid 39167182)
13. Gilron I, Coderre TJ. Emerging drugs in neuropathic pain. Expert Opin Emerg Drugs 2007; 12: 113-26 (Pubitemid 46490733)
14. Cruccu G, Sommer C, Anand P, et al. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol 2010; 17: 1010-8
15. Van Dam PS. Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives. Diabetes Metab Res Rev 2002; 18 (3): 176-84
16. Low PA, Nickander KK, Tritschler HJ. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 1997; 46 Suppl. 2: S38-42 (Pubitemid 27377396)
17. Ziegler D. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review. Treat Endocrinol 2004; 3 (3): 173-89 (Pubitemid 38724503)
18. Wallace DC. Mitochondrial DNA. Methods Mol Biol 2002; 197: 3-54
19. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-67 (Pubitemid 26070354)
20. Maier CM, Chan PH. Role of superoxide dismutase in oxidative damage and neurodegenerative disorders. Neuroscientist 2002; 8 (4): 323-34 (Pubitemid 34824016)
21. Nourooz-Zadeh J, Tajaddini-Sarmadi J, McCarthy S, et al. Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes 1995; 44: 1054-8
22. Wang ZQ, Porreca F, Cuzzocrea S, et al. A newly identified role for superoxide in inflammatory pain. J Pharmacol Exp Ther 2004; 309 (3): 869-78 (Pubitemid 38669673)
23. Kimura J. Nerve conduction and needle electromyography. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy. 4th ed. Philadelphia (PA): Saunders, 2005: 899-969
24. Albers JW, Brown MB, Sima AA, et al. Nerve conduction measures in mild diabetic neuropathy in the Early Diabetes Intervention Trial: the effects of age, sex, type of diabetes, disease duration, and anthropometric factors. Tolrestat Study Group for the Early Diabetes Intervention Trial. Neurology 1996; 46: 85-91 (Pubitemid 26156107)
25. Kiziltan ME, Gunduz A, Kiziltan G, et al. Peripheral neuropathy in patients with diabetic foot ulcera: clinical and nerve conduction study. J Neurol Sci 2007; 258: 75-9 (Pubitemid 46874480)
26. Shaikh AS, Somani RS. Animal models and biomarkers of neuropathy in diabetic rodents. Indian J Pharmacol 2010; 42 (3): 129-34
27. Edwards JL, Vincent AM, Cheng HT, et al. Diabetic neuropathy: mechanisms to management. Pharmacol Ther 2008; 120: 1-34
28. Ziegler D, Nowak H, Kempler P, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 2004; 21: 114-21 (Pubitemid 38221809)
29. Vincent AM, Russell JW, SulliVan KA, et al. SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy. Exper Neurol 2007; 208: 216-27 (Pubitemid 350101499)
30. Ziegler D. Painful diabetic neuropathy. Diabetes Care 2009; Suppl. 2 (32): S414-9